Skip to Main Content

Paper Details

Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.
Nat Cancer
25
2021
CLL, CLL cells, Chronic Lymphocytic Leukemia, MYC, PD, chronic lymphocytic leukemia, mTOR, patients, tumors
Author NameAffiliation
Elias CampoInstitut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
Elias Campo
Elias CampoHospital Clinic de Barcelona, University of Barcelona
Andrea JacobsInstitute of Molecular Health Sciences, ETH Zurich
Bernd BodenmillerInstitute of Molecular Health Sciences, ETH Zurich
Bernd BodenmillerInstitute of Molecular Health Sciences, ETH Zurich
Wolfgang Huber
Wolfgang Huber
Wolfgang Huber
Wolfgang Huber
  • 1 - 10

Datasets

Release 1.2